SOPHiA GENETICS SA (SOPH) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "SOPH"
      ],
      "issuer_cik": "0001840706",
      "owner_cik": "0002014308",
      "accession_number": "0001840706-26-000344",
      "form_type": "4",
      "filing_date": "2026-10-14",
      "period_of_report": "2026-10-12",
      "issuer_name": "SOPHiA GENETICS SA",
      "issuer_trading_symbol": "SOPH",
      "owner_name": "Menu Philippe",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Medical Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-12",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 5000,
      "transaction_price_per_share": 7.2606,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 195993,
      "transaction_value": 36303,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c)."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.17 to $7.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
        }
      ]
    },
    {
      "tickers": [
        "SOPH"
      ],
      "issuer_cik": "0001840706",
      "owner_cik": "0002007050",
      "accession_number": "0001840706-26-000340",
      "form_type": "4",
      "filing_date": "2026-10-14",
      "period_of_report": "2026-10-12",
      "issuer_name": "SOPHiA GENETICS SA",
      "issuer_trading_symbol": "SOPH",
      "owner_name": "Camblong Jurgi",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Executive Chairman",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-12",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 8500,
      "transaction_price_per_share": 7.2554,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 3387150,
      "transaction_value": 61670.9,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c)."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.15 to $7.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.